-
Disease Research and Policy. "
Achaogen Announces Plazomicin Granted QIDP
Designation by FDA" (Press release).
Achaogen, Inc. 8
January 2015. Archived...
-
David later co-founded
Achaogen (NASDAQ: AKAO),
focused on
developing treatments for antibiotic-resistant infections.
Achaogen developed Zemdri (plazomicin)...
- $12-million
contract with the San Francisco-based
biopharmaceutical company Achaogen,
sponsoring late-stage
development of C-scape, an
antibiotic used against...
-
Systems Incorporation, PharmaAthene,
Cleveland BioLabs Incorporation,
Achaogen (bankrupt in 2019),
Alnylam Pharmaceuticals, Avertis, Xoma Corporation...
